rss
Evid Based Nurs 12:14 doi:10.1136/ebn.12.1.14
  • Treatment

Benefits of early intensive glucose control in preventing diabetes-related complications were sustained for up to 10 years

R R Holman

Dr R R Holman, Churchill Hospital, Oxford, UK; rury.holman@dtu.ox.ac.uk

QUESTION

In patients with type 2 diabetes, do the benefits of early intensive glucose control in preventing diabetes-related complications continue after the intervention is stopped?

METHODS

Design:

randomised controlled trial (UK Prospective Diabetes Study [UKPDS]).

Allocation:

{concealed}.*

Blinding:

blinded (outcome adjudication committee).

Follow-up period:

median 9 years after the end of the trial, 17 years total.

Setting:

23 centres in the UK.

Patients:

4209 patients 25–65 years of age {mean age 53 y, 60% men}* who had newly diagnosed type 2 diabetes and fasting plasma glucose concentrations >6.0 mmol/l (108 mg/dl) and <15.0 mmol/l (270 mg/dl) after 3 months of dietary therapy. Exclusion criteria included ketonuria, elevated serum creatinine, recent myocardial infarction, angina, …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article